According to the research report titled ‘Asia Pacific Vascular Graft Market Forecast 2027 By Raw Material, By Application, By End-use, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with Market Study Report, Asia Pacific vascular graft market is poised to record a healthy CAGR through 2027.
 

Asia Pacific vascular graft market growth is mainly driven by increasing cases of diabetes & cardiovascular diseases, growing kidney failure cases, along with rising percentage of geriatric population are the major factors driving Moreover, technological innovations in the medical field are significantly enhancing the industry outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4037686/
 

Notably, many countries in the region like Japan and China have a lower death rate due the longer lifespan of the population. This resulted in an increase in number of chronic diseases like thoracic and abdominal aortic aneurysms, consequently augmenting the demand for vascular grafts.
 

Speaking of the challenges in this domain, lack of skilled professionals in developing countries and infections associated with vascular graft are negatively impacting the remuneration scope.
 

Considering application range, Asia Pacific vascular graft industry is segmented into peripheral vascular repair, endovascular aneurysm repair, and hemodialysis access. Among these, peripheral vascular repair segment accounted for USD 121.2 million in 2020, and is anticipated to expand substantially in the upcoming years due to rising Peripheral Arterial Disease (PAD) cases, and lesser complications involved in using vascular grafts in this procedure.
 

Speaking of raw material type, the marketplace is categorized into EPTFE grafts, polyester grafts, biosynthetic grafts, and polyurethane grafts. As cited in the report, polyester graft segment is expected to grow at 7.5% CAGR through 2027, as it has high success rate, provides a protective biological seal which prevents infections, and is more suitable for human use as it has undergone several technological advancements.
 

Considering regional outlook, Japan industry is poised to record a CAGR of 7% by 2027, owing to presence of a large elderly population based aged 65 and above and subsequent increase in the number of age-related ailments in the country.
 

Prominent players influencing the Asia Pacific vascular graft industry trends are CryoLife Inc., Endologix Inc., W. L. Gore & Associates Inc., Terumo Corporation, Medtronic plc, LeMaitre Vascular Inc., Getinge AB, Cook Medical Inc., B. Braun Melsungen AG, and Becton, Dickinson and Company.